Abstract

Tumor metastasis is a hallmark of cancer. The communication between cancer-derived exosomes and stroma plays an irreplaceable role in facilitating pre-metastatic niche formation and cancer metastasis. However, the mechanisms underlying exosome-mediated pre-metastatic niche formation during colorectal cancer (CRC) liver metastasis remain incompletely understood. Here we identified HSPC111 was the leading upregulated gene in hepatic stellate cells (HSCs) incubated with CRC cell-derived exosomes. In xenograft mouse model, CRC cell-derived exosomal HSPC111 facilitated pre-metastatic niche formation and CRC liver metastases (CRLM). Consistently, CRC patients with liver metastasis had higher level of HSPC111 in serum exosomes, primary tumors and cancer-associated fibroblasts (CAFs) in liver metastasis than those without. Mechanistically, HSPC111 altered lipid metabolism of CAFs by phosphorylating ATP-citrate lyase (ACLY), which upregulated the level of acetyl-CoA. The accumulation of acetyl-CoA further promoted CXCL5 expression and secretion by increasing H3K27 acetylation in CAFs. Moreover, CXCL5-CXCR2 axis reinforced exosomal HSPC111 excretion from CRC cells and promoted liver metastasis. These results uncovered that CRC cell-derived exosomal HSPC111 promotes pre-metastatic niche formation and CRLM via reprogramming lipid metabolism in CAFs, and implicate HSPC111 may be a potential therapeutic target for preventing CRLM.

Highlights

  • Colorectal cancer (CRC) is the third most common malignancy and has risen to the second leading cause of cancer-related death worldwide [1]

  • To compare the abilities of educating hepatic stellate cells (HSCs) into Cancer-associated fibroblasts (CAFs) among the four CRC cell-derived exosomes, the expression of α-SMA and FAP in treated HSCs were evaluated by western blot, which showed most highly in LX-2 cells incubated with HCT116-derived exosomes (ExoHCT116) (Fig. 1B)

  • QRT-PCR showed that HSPC111 mRNA have no significant change in LX-2 cells incubated with ExoHCT116 compared with control (Fig. 1F), which indicated that the elevated HSPC111 protein in LX-2 cells was delivered by CRC cell-derived exosomes

Read more

Summary

INTRODUCTION

Colorectal cancer (CRC) is the third most common malignancy and has risen to the second leading cause of cancer-related death worldwide [1]. Exosomes, ranging from 50–160 nm in diameter, are cancerderived vesicles to participate in pre-metastatic niche formation by deliver tumor products including proteins, nucleic acids and lipid to distant organs, and can transform fibroblasts to CAFs [11, 12]. In our previous study [15], we revealed that CRC cells show specific metabolic reprogramming during the process of liver metastasis. Most studies have focused on the metabolic changes of CAFs resident in the primary tumor [17, 18], and there remains little known about the mechanism of metabolic reprogramming of CAFs in the pre-metastatic niche during the process of CRC liver metastasis. We uncovered the critical role of CRC cell-derived exosomal HSPC111 in facilitating pre-metastatic niche formation by inducing lipid metabolic reprogramming of CAFs in liver. Four weeks after CRC cells injection, mice were euthanized and liver metastasis were

MATERIALS AND METHODS
RESULTS
DISCUSSION
ETHICS APPROVAL AND CONSENT TO PARTICIPATE
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call